BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

738 related articles for article (PubMed ID: 25713030)

  • 1. Alteration of gut microbiota by vancomycin and bacitracin improves insulin resistance via glucagon-like peptide 1 in diet-induced obesity.
    Hwang I; Park YJ; Kim YR; Kim YN; Ka S; Lee HY; Seong JK; Seok YJ; Kim JB
    FASEB J; 2015 Jun; 29(6):2397-411. PubMed ID: 25713030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Red pitaya betacyanins protects from diet-induced obesity, liver steatosis and insulin resistance in association with modulation of gut microbiota in mice.
    Song H; Chu Q; Yan F; Yang Y; Han W; Zheng X
    J Gastroenterol Hepatol; 2016 Aug; 31(8):1462-9. PubMed ID: 26699443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota: Firmicutes and Bacteroidetes involved in insulin resistance by mediating levels of glucagon-like peptide 1.
    Greenhill C
    Nat Rev Endocrinol; 2015 May; 11(5):254. PubMed ID: 25781856
    [No Abstract]   [Full Text] [Related]  

  • 4. 3-(4-Hydroxy-3-methoxyphenyl)propionic Acid Produced from 4-Hydroxy-3-methoxycinnamic Acid by Gut Microbiota Improves Host Metabolic Condition in Diet-Induced Obese Mice.
    Ohue-Kitano R; Taira S; Watanabe K; Masujima Y; Kuboshima T; Miyamoto J; Nishitani Y; Kawakami H; Kuwahara H; Kimura I
    Nutrients; 2019 May; 11(5):. PubMed ID: 31075850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity.
    Murphy EF; Cotter PD; Hogan A; O'Sullivan O; Joyce A; Fouhy F; Clarke SF; Marques TM; O'Toole PW; Stanton C; Quigley EM; Daly C; Ross PR; O'Doherty RM; Shanahan F
    Gut; 2013 Feb; 62(2):220-6. PubMed ID: 22345653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin prevents obesity through modulation of gut microbiota in mice.
    Xu P; Wang J; Hong F; Wang S; Jin X; Xue T; Jia L; Zhai Y
    J Pineal Res; 2017 May; 62(4):. PubMed ID: 28199741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral hydroxysafflor yellow A reduces obesity in mice by modulating the gut microbiota and serum metabolism.
    Liu J; Yue S; Yang Z; Feng W; Meng X; Wang A; Peng C; Wang C; Yan D
    Pharmacol Res; 2018 Aug; 134():40-50. PubMed ID: 29787870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of pyrosequencing and DNA barcodes to monitor variations in Firmicutes and Bacteroidetes communities in the gut microbiota of obese humans.
    Armougom F; Raoult D
    BMC Genomics; 2008 Dec; 9():576. PubMed ID: 19046425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prebiotic fibres dose-dependently increase satiety hormones and alter Bacteroidetes and Firmicutes in lean and obese JCR:LA-cp rats.
    Parnell JA; Reimer RA
    Br J Nutr; 2012 Feb; 107(4):601-13. PubMed ID: 21767445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary modulation of clostridial cluster XIVa gut bacteria (Roseburia spp.) by chitin-glucan fiber improves host metabolic alterations induced by high-fat diet in mice.
    Neyrinck AM; Possemiers S; Verstraete W; De Backer F; Cani PD; Delzenne NM
    J Nutr Biochem; 2012 Jan; 23(1):51-9. PubMed ID: 21411304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota mediates the protective effects of dietary β-hydroxy-β-methylbutyrate (HMB) against obesity induced by high-fat diets.
    Duan Y; Zhong Y; Xiao H; Zheng C; Song B; Wang W; Guo Q; Li Y; Han H; Gao J; Xu K; Li T; Yin Y; Li F; Yin J; Kong X
    FASEB J; 2019 Sep; 33(9):10019-10033. PubMed ID: 31167080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice.
    Everard A; Lazarevic V; Derrien M; Girard M; Muccioli GG; Neyrinck AM; Possemiers S; Van Holle A; François P; de Vos WM; Delzenne NM; Schrenzel J; Cani PD
    Diabetes; 2011 Nov; 60(11):2775-86. PubMed ID: 21933985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High fat diet drives obesity regardless the composition of gut microbiota in mice.
    Rabot S; Membrez M; Blancher F; Berger B; Moine D; Krause L; Bibiloni R; Bruneau A; Gérard P; Siddharth J; Lauber CL; Chou CJ
    Sci Rep; 2016 Aug; 6():32484. PubMed ID: 27577172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota-mediated xanthine metabolism is associated with resistance to high-fat diet-induced obesity.
    Wei B; Wang S; Wang Y; Ke S; Jin W; Chen J; Zhang H; Sun J; Henning SM; Wang J; Wang H
    J Nutr Biochem; 2021 Feb; 88():108533. PubMed ID: 33250443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotics-induced perturbations in gut microbial diversity influence metabolic phenotypes in a murine model of high-fat diet-induced obesity.
    Liu D; Wen B; Zhu K; Luo Y; Li J; Li Y; Lin H; Huang J; Liu Z
    Appl Microbiol Biotechnol; 2019 Jul; 103(13):5269-5283. PubMed ID: 31020379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDG-1, an Ophiopogon polysaccharide, regulate gut microbiota in high-fat diet-induced obese C57BL/6 mice.
    Shi LL; Li Y; Wang Y; Feng Y
    Int J Biol Macromol; 2015 Nov; 81():576-83. PubMed ID: 26321425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insoluble Dietary Fiber from Pear Pomace Can Prevent High-Fat Diet-Induced Obesity in Rats Mainly by Improving the Structure of the Gut Microbiota.
    Chang S; Cui X; Guo M; Tian Y; Xu W; Huang K; Zhang Y
    J Microbiol Biotechnol; 2017 Apr; 27(4):856-867. PubMed ID: 28173692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice.
    Carvalho BM; Guadagnini D; Tsukumo DML; Schenka AA; Latuf-Filho P; Vassallo J; Dias JC; Kubota LT; Carvalheira JBC; Saad MJA
    Diabetologia; 2012 Oct; 55(10):2823-2834. PubMed ID: 22828956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity.
    Vrieze A; Out C; Fuentes S; Jonker L; Reuling I; Kootte RS; van Nood E; Holleman F; Knaapen M; Romijn JA; Soeters MR; Blaak EE; Dallinga-Thie GM; Reijnders D; Ackermans MT; Serlie MJ; Knop FK; Holst JJ; van der Ley C; Kema IP; Zoetendal EG; de Vos WM; Hoekstra JB; Stroes ES; Groen AK; Nieuwdorp M
    J Hepatol; 2014 Apr; 60(4):824-31. PubMed ID: 24316517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiota and epigenetic regulation of inflammatory mediators in type 2 diabetes and obesity.
    Remely M; Aumueller E; Jahn D; Hippe B; Brath H; Haslberger AG
    Benef Microbes; 2014 Mar; 5(1):33-43. PubMed ID: 24533976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.